Le Lézard
Classified in: Health, Covid-19 virus
Subject: ACC

Orexo Publishes the Annual Report for 2019


UPPSALA, Sweden, March 26, 2020 /PRNewswire/ --  Annual Report, including the Sustainability Report, for the 2019 fiscal year has been published. The Annual Report can be downloaded on the company's website, www.orexo.com  (investors/reports, presentations and audiocasts), and a PDF is also attached to this press release.

In regards to ESMA's recommendations the Report also includes the operational and financial impact the company sees due to COVID-19 (CEO Comments, Board of Directors Report and Note 34), which still is in line with earlier communicated information within this field. Orexo will continue to assess the situa­tion and will be providing a further update in the Q1 report scheduled on April 28, 2020. 

About Orexo

Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs mainly within the growing space of addiction. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product Zubsolv® for treatment of opioid use disorder. Total net sales for 2019 amounted to SEK 845 million and the number of employees was 127. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed.

For further information, please contact

Orexo AB (publ.)

Lena Wange,
IR & Communications Manager
Tel: +46-18-780-88-00
e-mail: [email protected]

For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube.

This information is information that Orexo AB (publ.) is obliged to make public in accordance with the

Securities Market Act. The information was submitted for publication at 2 pm CET on March 26, 2020.  

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-publishes-the-annual-report-for-2019,c3069475

The following files are available for download:

https://mb.cision.com/Main/694/3069475/1218372.pdf

Orexo publishes the Annual Report for 2019

SOURCE Orexo


These press releases may also interest you

at 06:50
U.S. FDA Approves Pfizer's BEQVEZtm (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:15
Carter's, Inc. Reports First Quarter Fiscal 2024 Results
Carter's, Inc. , the largest branded marketer in North America of apparel exclusively for babies and young children, today reported its first quarter fiscal 2024 results. "We exceeded our sales and earnings objectives in the first quarter," said...

at 06:01
Aon Reports First Quarter 2024 Results
First Quarter Key Metrics Total revenue increased 5% to $4.1 billion, including organic revenue growth of 5%Operating margin decreased 210 basis points to 36.0%, and operating margin, adjusted for certain items, increased 100 basis points to 39.7%EPS...

at 06:00
Ball Reports First Quarter 2024 Results
Highlights First quarter U.S. GAAP total diluted earnings per share of $11.61, inclusive of gain on aerospace sale, vs. 56 cents in 2023First quarter comparable diluted earnings per share of 68 cents vs. 69 cents in 2023Global beverage can shipments...

at 05:45
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDEL
The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation . Shareholders who...

at 05:45
Class Action Filed Against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (KIND) - April 29, 2024 Deadline to Join - Contact The Gross Law Firm
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

More news about Covid-19 virus...


News published on and distributed by: